![Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022 - ScienceDirect Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2667368122000390-gr2.jpg)
Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022 - ScienceDirect
![Association between beta-blocker use and obesity in Hong Kong Chinese elders: a post-hoc analysis | HKMJ Association between beta-blocker use and obesity in Hong Kong Chinese elders: a post-hoc analysis | HKMJ](https://www.hkmj.org/system/files/hkmj198077-table-4.jpg)
Association between beta-blocker use and obesity in Hong Kong Chinese elders: a post-hoc analysis | HKMJ
![Association between beta-blocker use and obesity in Hong Kong Chinese elders: a post-hoc analysis | HKMJ Association between beta-blocker use and obesity in Hong Kong Chinese elders: a post-hoc analysis | HKMJ](https://www.hkmj.org/system/files/hkmj198077-table-2.jpg)
Association between beta-blocker use and obesity in Hong Kong Chinese elders: a post-hoc analysis | HKMJ
![Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management | Scientific Reports Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-22787-8/MediaObjects/41598_2018_22787_Fig1_HTML.jpg)